Furthermore, Cosset et al. [27] studied the association between tyrosine kinase inhibitor (TSI) treatment and TWIST1 expression in chronic myeloid leukemia (CML). Here, TWIST1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.